![]() ![]() The Center for Personalized Cancer Therapy is a collaborative venture between the University of Massachusetts Boston and the Dana Farber/Harvard Cancer Center (DF/HCC) and funded by the Massachusetts Life Sciences Center. (Nasdaq: TXG) today announced that it has entered into a definitive agreement to acquire ReadCoor, Inc., developer of foundational In Situ technologies, based in Boston, for cash and stock consideration of 350 million. Generate consistent results: Reduce single cell data variability, generating reproducible and consistent results. 3 minutes Continuing on its mission of mastering biology to advance human health, 10x Genomics, Inc. Additional instruments include a Biomek FXp automated workstation, and a QuantStudio 12K Flex Real-Time PCR System. 10x Genomics Chromium Connect The 10x Genomics Connect addresses the variability of single cell/nucleus preps by automating the complete process from cell/nucleus suspensions to libraries. An asymetrical sequencing profile is used to sequence stand alone 10X single cell 5 libraries. The Core offers cost-effective massively parallel sequencing with the Illumina HiSeq 2500 (v4, 1TB enabled) and Illumina MiSeq platforms 10X Genomics Chromium Single Cell Sequencing Platform Nanostring nCounter Analysis System next-generation sequencing library preparation from RNA and DNA, and nucleic acid quality assessments using Bioanalyzer, Tapestation, Nanodrop and Qubit assays. Stem Cell Biology Immuno-oncology Infectious disease Single cell libraries prepared using the 10X Chromium Controller are Illumina compatable and will be sequenced using the NovaSeq 6000. We help investigators and clinicians analyze samples, identify genetic variants contributing to disease risk, and reveal complex mechanisms involved in human disease. ![]() The Core leverages cutting-edge technologies and next-generation sequencing capabilities for research and clinical applications. the Division of Immunology, Boston Childrens Hospital (BCH) as Post-doctoral fellow. Potential Effect: cancer10x EWGS HEALTH GUIDELINE. and a 10X Chromium Controller for droplet-based analysis. Custom run parameters for Single Cell Sequencing using the 10X Chromium platform is also available (rates available in iLabs) - Illumina NextSeq 2000 The Illumina NextSeq 2000 System is a powerful and efficient high-throughput sequencing system that supports a range of applications and study sizes. The CPCT Genomics Core enables UMass Boston investigators and academic and industry collaborators to carry out basic and translational genomics research. EWGs Tap Water Database chemical contaminant results for Boston Water and Sewer Commission (MWRA).
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |